RAMOS-LIMA, Francisco J., Oldřich VRÁNA, Adoración G. QUIROGA, Carmen NAVARRO-RANNINGER, Anna HALÁMIKOVÁ, Hana RYBNÍČKOVÁ, Lenka HEJMALOVÁ and Viktor BRABEC. Structural Characterization, DNA Interactions, and Cytotoxicity of New Transplatin Analogues Containing One Aliphatic and One Planar Heterocyclic Amine Ligand. Journal of Medicinal Chemistry. USA: American Chemical Society, 2006, vol. 49, No 8, p. 2640-2651. ISSN 0022-2623.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Structural Characterization, DNA Interactions, and Cytotoxicity of New Transplatin Analogues Containing One Aliphatic and One Planar Heterocyclic Amine Ligand
Name in Czech Strukturní charakterizace, interakce s DNA, a cytotoxicita nových transplatinových analogů obsahujících jeden alifatický a jeden heterocyklický amino ligand
Authors RAMOS-LIMA, Francisco J. (724 Spain), Oldřich VRÁNA (203 Czech Republic), Adoración G. QUIROGA (724 Spain), Carmen NAVARRO-RANNINGER (724 Spain), Anna HALÁMIKOVÁ (703 Slovakia), Hana RYBNÍČKOVÁ (203 Czech Republic), Lenka HEJMALOVÁ (203 Czech Republic) and Viktor BRABEC (203 Czech Republic, guarantor).
Edition Journal of Medicinal Chemistry, USA, American Chemical Society, 2006, 0022-2623.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10610 Biophysics
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.115
Organization unit Faculty of Science
UT WoS 000236979100029
Keywords (in Czech) transplatina; protinádorový; DNA
Keywords in English transplatin; antitumor; DNA
Tags antitumor, DNA, transplatin
Tags International impact, Reviewed
Changed by Changed by: Mgr. Lenka Hejmalová, učo 3147. Changed: 22/6/2009 14:15.
Abstract
We report in the present work new analogues of clinically ineffective transplatin in which one ammine group was replaced by aliphatic and the other by a planar heterocyclic ligand, namely trans-[PtCl(2)(isopropylamine)(3-(hydroxymethyl)-pyridine)], 1, and trans-[PtCl(2)(isopropylamine)(4-(hydroxymethyl)-pyridine)], 2. The new compounds, in comparison with parent transplatin, exhibit radically enhanced activity in tumor cell lines both sensitive and in particular resistant to cisplatin. Concomitantly, the DNA binding mode of 1 and 2 compared to parent transplatin and other antitumor analogues of transplatin in which only one ammine group was replaced is also different. The results also suggest that the reactions of glutathione and metallothionein-2 with compounds 1 and 2 do not play a crucial role in their overall biological effects. In addition, the monofunctional adducts of 1 and 2 are quenched by glutathione considerably less than the adducts of transplatin, which may potentiate cytotoxic effects of these new platinum complexes.
Abstract (in Czech)
Tato práce popisuje nové analogy klinicky neúčinné tranplatiny, kde je nahrazena jedna aminoskupina alifatickým řetězcem a druhá aminoskupina je nahrazena planárním heterocyklickým ligantem,a to trans-[PtCl(2)(isopropylamine)(3-(hydroxymethyl)-pyridine)], 1, and trans-[PtCl(2)(isopropylamine)(4-(hydroxymethyl)-pyridine)], 2.
PrintDisplayed: 19/7/2024 17:05